Biotron Limited (ASX:BIT)

Michelle Miller
CEO
Market Cap (AUD): 51.23M
Sector: Health Care
Last Trade (AUD): 0.086 +0 (+0%)
Tab Bar

1. About

Biotron Limited (Biotron) is a publicly listed Australian biotechnology company based in Sydney, NSW. Biotron is committed to the development and commercialisation of novel small molecule antiviral therapeutics targeting Hepatitis C virus (HCV) and HIV-1. The Company has identified a new class of viral proteins as targets for potential intervention, and is developing novel small molecule therapeutics that target these proteins, specifically the p7 protein of HCV and Vpu protein of HIV.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk